STXS Stereotaxis Inc
1,764
$1.98
$0.04
(1.98%)
| Watchers | 1,764 |
| 52-Wk Low | $1.33 |
| 52-Wk High | $3.29 |
| Market Cap | $163.63M |
| Volume | 275,268.00 |
| 52-Wk High | $3.29 |
| 52-Wk Low | $1.33 |
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United StatesGlobe Newswire • 3 months ago
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Share to Feed
ST. LOUIS, March 04, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
ST. LOUIS, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the first treatment of...
ST. LOUIS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it...
ST. LOUIS, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that the first patients have...